Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gout × Allopurinol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 9 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 7 Burkitt Lymphoma 7 Leukemia, Lymphocytic, Chronic, B-Cell 6 Multiple Myeloma 5 Lymphoma, Follicular 5 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Prolymphocytic 4 Tumor Lysis Syndrome 3 Neoplasms, Plasma Cell 3 Myeloproliferative Disorders 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hyperuricemia 3 Hodgkin Disease 3 Congenital Abnormalities 3 Primary Myelofibrosis 2 Neoplasms 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell 2 Leukemia, Plasma Cell 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Biphenotypic, Acute 2 HIV Infections 2

Interventions

Omeprazole 1 Naproxen 1 Febuxostat 1 Colchicine 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡